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Abstract: Adeno-associated virus (AAV) is one of the most promising gene transfer 
vector types featuring long-term gene expression and low toxicity. The lack of 
pathogenicity and the availability of many serotypes augmented the applicability of AAV 
virions in gene therapy applications. The recombinant AAV capsid includes the 
therapeutic protein-coding transgene as well as a promoter to initiate translation and a 
poly A sequence portion for stabilization. Current AAV manufacturing technologies, 
however, cannot guarantee the generation of only full capsids, i.e., including the entire 
required genome. Partially filled and empty capsids are also part of the product, 
decreasing in this way the efficacy and safety upon clinical translation. Therefore, rapid, 
accurate and QC friendly analysis of the full and empty capsid ratio is of high importance 
during AAV vector manufacturing and release testing. In this paper, an automated 
capillary isoelectric focusing technique is introduced, readily applicable in the 
biopharmaceutical industry for fast and efficient determination of the full and empty 
capsid ratio. The method also reveals information about the proportion of partially filled 
capsids. For higher resolution (<0.1 pI unit), mixtures of wide and narrow range 
ampholytes were utilized. The isoelectric point and peak area percentage reproducibility 
(RSD) of the mixed ampholyte assay were as low as 1.67% and 2.45 %, respectively, 
requiring only 65 nL of sample volume per injection. 
Keywords: Adeno Associated Virus, capillary electrophoresis, Transmission electron microscopy, Isoelectric 
focusing, Full/empty capsid, Transgene. 
1. INTRODUCTION 
 One of the most frequently utilized gene therapy 
vectors is Adeno-associated virus (AAV), featuring very 
low immunogenicity and different tropisms for multiple 
cell types [1, 2]. The virus comprises a protein shell, 
also referred to as the capsid with an icosahedral 
shape of approximately 20-25 nm in diameter, 
composed of 60 viral protein subunits [3, 4]. A single-
stranded DNA molecule of approximately 4700-4800 
bases is enclosed inside the capsid. This DNA in 
recombinant AAVs for gene therapy has three major 
elements, including the 145 nucleotide long inverted 
terminal repeats (ITR) at both ends, the promoter 
sequence and the therapeutic gene (transgene) [5]. 
During the manufacturing process of AAV vectors, 
many of the capsids either are not or are partially 
incorporated with the required DNA load (fragments or 
truncated). This can lead to a significantly low 
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production yield of 10-20%, which results in a decrease 
in efficacy and an increase in potential safety risks. 
Hence, it is critical to be able to quantitatively 
determine the level of full, empty as well as partially 
filled AAV vectors. 
 Traditional methodologies used for the 
determination of the full vs empty AAV capsid ratios 
include spectrophotometry, analytical ultracentrifu-
gation (AUC), electron microscopy (EM), ion-exchange 
chromatography (IEX), charge detection mass 
spectrometry (CDMS) as well as combined results 
obtained from both ELISA and qPCR data [6]. While 
some of these methods are well accepted and easy to 
use, they have limitations in accuracy and precision. 
Spectrophotometry based techniques use the UV 
absorbance ratio of the sample, measured at 260 nm 
and 280 nm to reveal the relationship between the 
protein to nucleic acid content [7]. While this approach 
is simple and fast, it suffers from impurity interferences 
and low accuracy. One of the broadly used analytical 
and preparative approaches capable of separating full, 
partially filled and empty capsids is analytical 
1875-5666/20 $65.00+.00 © 2020 Bentham Science Publishers 
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ultracentrifugation [8]. AUC has a large sample 
requirement and is difficult to utilize as a rapid quality 
control (QC) release assay system. Transmission and 
cryo-electron microscopy, as well as atomic force 
microscopy [9-12] are other frequently used methods 
capable of counting the number of full and empty 
capsids in a sample population, however, these 
methods have difficulties in determining the extent of 
DNA content in partially filled capsids. In addition, the 
evaluation of electron microscopy data is time-
consuming, making it less desirable in the QC and 
release testing environment. EM methods also heavily 
rely on the analyst’s interpretation of the data, which 
can be somewhat subjective. Ion-exchange 
chromatography (IEX) is a quantitative but low-
resolution technique for full and empty capsid ratio 
determination [13, 14]. IEX also requires larger sample 
amounts and suffers from serotype dependence. Mass 
spectrometry (MS) based approaches, such as charge 
detection MS, can readily detect full, partially filled and 
empty capsids, yet commercially not available for 
routine use [15].  
 The drawbacks of the above listed techniques 
called for more comprehensive, fast, easy to perform, 
robust approaches that are appropriate for QC/release 
testing to quantify the full and empty AAV capsid ratio 
with the possibility to reveal information on partially 
filled species, AAV charge heterogeneity and 
impurities. Capillary isoelectric focusing (cIEF) is a 
well-established bioanalytical technique in the 
biopharmaceutical industry, capable of separating 
closely related species, based on their isoelectric 
points, such as charge variants [16]. Due to their 
negatively charged DNA load, full AAV capsids 
generally have lower isoelectric points compared to 
their empty or partially filled counterparts [17], making 
cIEF a promising tool to fill the gaps described above. 
In this paper, we introduce an automated capillary 
isoelectric focusing method, featuring low sample 
volume requirements in conjunction with the use of 
narrow pH range ampholytes (≤0.1 pH unit resolution) 
for rapid (<45 min) QC friendly analysis of full, empty 
and partially filled AAV capsids.  
2. MATERIALS AND METHODS 
2.1. Chemicals 
 Phosphoric acid, sodium hydroxide, acetic acid, L-
arginine, iminodiacetic acid and all other chemicals 
were from Sigma-Aldrich (St Louis, MO). AAV samples 
were from SignaGen Laboratories (Rockville, MD) and 
Vigene Biosciences (Rockville, MD) with the serotypes 
specified below. The components of the Advanced 
cIEF Starter Kit were used with the N-CHO coated 
capillary (Sciex, Framingham, MA), unless specified 
otherwise. All solutions were filtered through 5 μm 
syringe filters prior to use.  
2.2. Sample Preparation  
 The master-mix solution was prepared by 
combining 200 μL of 3 M urea - cIEF gel solution, 12 
μL of ampholytes (pH range specified in the relevant 
sections), 20 μL of cathodic stabilizer (500 mM L-
Arginine), 2 μL of anodic stabilizer (200 mM 
iminodiacetic acid) and 2 μL of each pI marker used. 
The following AAV serotypes were used in the 
experiments from SignaGen Laboratories (Rockville, 
MD): AAV1-CMV-GFP (titer: 1.46 x1013 GC/mL), AAV3-
Cre-GFP (titer: 1.02 x1013 GC/mL), AAV5-CMV-GFP 
(titer: 1.53 x1013 GC/mL) and AAV9-CMV-GFP (titer: 
3.12 x1013 GC/mL). AAV8 of pAV-CMV-GFP Empty 
Capsid sample with a titer of 5.10 x1012 GC/mL was 
used as enriched empty capsids, while packaged AAV8 
of the pAV-CMV-GFP sample with a titer of 1.10 x1013 
GC/mL as enriched full capsids, both from Vigene 
Biosciences (Rockville, MD). 3 μL of AAV samples 
were mixed with 24 μL of master mix and transferred 
into nanoVials (Sciex) for cIEF analysis. Either the 
Pharmalyte, 3-10 wide pH range ampholyte (GE 
Healthcare) alone, or its mixtures with SERVALYT 6-8 
narrow pH ampholyte (Serva, Heidelberg, Germany) or 
SH AESlytes 7-8 narrow pH ampholyte (Advanced 
Electrophoresis Solutions, Cambridge, Ontario) were 
used at various ratios to fine-tune resolution.  
2.3. Capillary Isoelectric Focusing (cIEF) 
 All cIEF experiments were performed in normal 
polarity separation mode (anode at the injection side) 
on a PA 800 Plus Pharmaceutical Analysis system 
(SCIEX), equipped with a UV detector (280 nm filter). 
The separation capillary was filled with the relevant 
ampholyte solutions, as defined in the ‘Results and 
Discussion’ section. The anolyte was 200 mM 
phosphoric acid, while the catholyte was 300 mM 
sodium hydroxide. The chemical mobilizer was 350 mM 
acetic acid and the capillary cleaning solution was 4.3 
M urea. The cathodic and anodic stabilizer solutions 
were 500 mM L-Arginine and 200 mM iminodiacetic 
acid (IDA), respectively. The N-CHO coated capillary 
was used for all cIEF analyses and the separation 
temperature was maintained at 20°C. The data were 
collected and analyzed by the 32 Karat Software 
version 10.3.  
2.4. Transmission Electron Microscopy (TEM) 
 One drop (~5 µl) of AAV5 sample was placed onto a 
TEM copper grid covered by a thin (3-5 nm) continuous 
carbon film. The excess sample was soaked up with a 
paper tissue. Phosphotungstic acid (2%) was used for 
staining the sample for 30 seconds. A 200 kV FEI 
Talos F200X transmission electron microscope 
(equipped with a field-emission gun) was used for the 
measurements (Thermo Fisher, Waltham, MA). The 
TEM bright-field images were taken at random places 
and constant magnification (1 µm field of view) with a 
4096 x 4096 pixel CMOS camera (FEI CETA). The 
evaluation was made by manual counting of at least 
5000 virus particles. 
3. RESULTS AND DISCUSSION  
 A pilot experiment was conducted first to 
understand the cIEF migration behavior of enriched full 
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and enriched empty AAV capsids, shown in Fig. 1. In 
this experiment, the wide pI range ampholyte (pH 3-10) 
was used in the separation capillary with sodium 
hydroxide in the cathode and phosphoric acid in the 
anode reservoirs. The upper trace depicts the 
electropherogram of the enriched full capsid sample. 
As one can observe, besides the peak corresponding 
to the full capsid (peak 3), a few transitional products 
were also detected (peak group 2) along with a small 
peak representing, in this case, the empty capsid (peak 
1), all focused between the pH 7.0 and 10.0 pI 
markers. The lower trace shows the separation of the 
sample containing the enriched empty capsid. Similar 
to the upper trace, peak 1 represents the empty, while 
peak group 2 represents the various partially filled 
transitional capsids and peak 3 the full capsid. These 
results suggested that the empty capsid focused at a 
higher pI value, while the full capsid at a lower pI value, 
the latter due to its negatively charged DNA load. The 
partially filled capsids focused between the empty and 
full capsid peaks, corresponding to the pI values 
defined by their actual DNA content.  
 After verifying the cIEF focusing order of the empty 
and full adeno associated virus capsids, five 
commercially available AAV samples of different 
serotypes (AAV1, AAV3, AAV5, AAV8 and AAV9) were 
analyzed using the wide pH range ampholyte (pH 3-10) 
as shown in Fig. 2. Trace (a) depicts a blank run, while 
the upper traces of (b-f) show the corresponding AAV 
serotype associated electropherograms. The pI values 
of the separated peaks were determined by a 
calibration plot using a pI marker mixture and were 
found as follows: AAV1 = pI 7.8-8.0; AAV3 = pI 8.7-9.0; 
AAV5 = pI 7.0-7.2; AAV8 = pI 7.0-7.5; AAV9 = pI 7.3-
7.5. Analysis of the AAV1 sample (trace b) revealed an 
overlapping peak distribution of the differently loaded 
capsids, i.e., empty, partially filled and full. The 
separation of the AAV3 (trace c) and AAV5 (trace d) 
samples featured two main peaks and a smaller one in 
between, considered to be corresponding to the empty, 
partially filled and full capsids. Again, the fact that the 
full capsids have lower pI values is due to the large 
amount of negative charges carried by the 
encapsulated DNA. AAV8 (trace e) and AAV9 (trace f) 
capsids focused on single broad peaks (the latter one 
with a shoulder), suggesting poor resolution of the 
variously filled capsid forms of these serotypes with the 
use of the wide pH range ampholyte.  
 As one can observe in Fig. 2, with the use of the 
wide pH range ampholyte, the analysis of the AAV5 
sample showed the well-resolved separation of the 
empty, partially filled and full capsid peaks (trace d). 
The full and empty percentage distribution of this 
sample from the processed cIEF data was determined 
as 43% and 57%, respectively. The calculation was 
made by applying the correction factor introduced by 
 
Fig. (1). Capillary isoelectric focusing of enriched empty (trace a) and enriched full (trace b) AAV capsids for migration/focusing 
order determination. Peaks: 1-empty, 2-transitional and 3-full capsids. Conditions: 20 cm effective length N-CHO capillary (50 
μm ID and 30 cm total length), filled with 3-10 wide pH range ampholyte containing background electrolyte. Catholyte: 300 mM 
sodium hydroxide, Anolyte: 200 mM phosphoric acid. Applied electric potential: 25 kV for the 15 min for the focusing step. 
Chemical mobilization step: 30 kV with 350 mM acetic acid for 30 min from the outlet reservoir. The separation temperature of 
the capillary cartridge was set at 20oC. (A higher resolution / colour version of this figure is available in the electronic copy of the 
article). 
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Goricar et al., [18] to alleviate any possible 
overestimation of the amounts of the full capsids that 
might have been caused by the 280 nm UV detection. 
This particular serotype was also subject to analysis by 
transmission electron microscopy (TEM), an orthogonal 
AAV capsid characterization method. Figure 3 shows a 
representative section of the TEM results, where the 
green circles and squares depict examples of full and 
empty capsid images, respectively. The arrows show 
the transitional capsids. The full to empty distribution 
using this method was assessed as 35% to 65%, by 
manually counting the capsid types, i.e., reasonably 
similar to that obtained with the cIEF method.  
 To quantify the capsid load distribution in some of 
the serotypes that resulted in either broad co-focused 
(AAV1) or non-separated single peaks (AAV8 and 9) 
with the use of the wide range ampholyte of pH 3-10, 
the resolution of the analysis was fine-tuned by mixing 
the wide range type with narrow range ones. Trace (a) 
in Figure 4 depicts the results obtained with the use of 
1:1 ratio of the wide range (pH 3-10) and narrow range 
(pH 6-8) ampholytes for the analysis of the AAV1 
sample. As one can observe, in contrast to the results 
obtained with the use of the wide range ampholyte only 
(Fig. 2, trace b), this particular sample was resolved 
into five separated peaks, apparently corresponding to 
the empty (peak 1), partially filled (peak 2) and full 
(peak 3) capsids. Peaks 4 and 5 are probably sample 
related impurities. The middle trace (b) in Fig. 4 shows 
the separation of the AAV8 capsid sample with the 2:1 
ratio of the wide and narrow range ampholytes 
resulting in a significant resolution increase in 
comparison to trace e in Fig. 2. The multiple peaks 
were obtained assumable corresponding to the empty  
 
Fig. (3). Analysis of the full and empty capsid distribution of 
the AAV5 sample by transmission electron microscopy 
(TEM). Green Circles: examples of full capsid images; Green 
Squares: examples of empty capsid images; Green Arrows: 
examples of transitional capsids. Conditions: TEM: 200 kV 
FEI Talos F200X transmission electron microscope with 
bright-field images taken at random places and constant 
magnification (1 µm field of view) with a 4096 x 4096 pixel 
CMOS camera. (A higher resolution / colour version of this 
figure is available in the electronic copy of the article). 
 
Fig. (2). Capillary isoelectric focusing analysis of five AAV capsid samples with different serotypes using the wide pH range 
ampholyte of pH 3-10. Traces: a) Blank, b) AAV1, c) AAV3, d) AAV5, e) AAV8 and f) AAV9. Peaks: 1-empty, 2-partially filled 
and 3-full capsids. Conditions were the same as in Fig. 1. (A higher resolution / colour version of this figure is available in the 
electronic copy of the article). 
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(peak 1), partially filled (peaks 2 and 3) and full (peak 
4) capsids. Another example of the usefulness of such 
pH range optimization is delineated in the upper trace 
of Fig. 4 (c), where a good separation of the AAV9 
sample is shown with the use of 2:1 ratio mixture of the 
wide and narrow range ampholytes. Please note when 
using the wide range ampholyte alone for this particular 
sample, only a single peak with a shoulder was 
observed (Fig. 2, trace f). However, applying the 2:1 
mixture of pH 3-10 and 6-8 ampholytes resulted in 
excellent separation of all major components, probably 
corresponding to the empty (peak 1), partially filled 
(peaks 2 and 3) and full (peak 4) capsids. Peak 5 here 
was also considered as sample related impurity. This 
particular sample apparently contained mostly partially 
filled capsids, with various DNA loads represented by 
the individual peaks of 2 and 3). The assay 
reproducibility was also evaluated for this sample 
based on 6 consecutive runs and the pI and peak area 
percent RSD values were 1.67 and 2.45%, 
respectively. 
 Interestingly, in some instances, further cIEF 
optimization did not bring about better separations. As 
an example, additional optimization by mixing the pH 3-
10 ampholyte with an ultra-narrow range type of pH 7-8 
in 2:1 ratio (Fig. 5, trace b) did not result in better 
separation of the AAV5 serotype as with the use of the 
2:1 ratio of pH 3-10 and pH 6-8 ampholyte mixture 
(trace a). Albeit, trace (b) in this example shows 9 
peaks, some of them might be just focusing on artifacts 
or spikes (e.g., peaks 2, 3 and 4). Trace (a), on the 
other hand, while featuring only five peaks, can be 
better evaluated from cIEF point of view with the empty 
(peak 1), full (peak 5) and partially filled (peaks 2-4) 
capsids.  
CONCLUSION 
In this paper, an automated cIEF based rapid and 
high-resolution method was introduced to determine 
the full/empty capsid ratios of different serotype AAV 
vectors.  The full capsids focused at the lower, while 
the empty ones at the higher pI regime, respectively, 
based on their DNA load. In addition, the generated 
data also provided information about the presence of 
partially filled capsids, focused in between. Mixing wide 
and narrow range ampholytes resulted in better 
separation of otherwise co-focusing full, transitional 
and empty capsids with very small pI value differences. 
The reproducibility of the assay, even with the mixed 
range ampholytes was  as low as 1.67% RSD for 
isoelectric point and 2.45% for peak area percentage 
determination. It is also important to note that the cIEF 
method required less than 5 μL of the total sample size 
for multiple runs, considering the typical injection 
volume of 65 nL.  
LIST OF ABBREVIATIONS 
AAV = Adeno Associated Virus 
AUC = Analytical ultracentrifugation 
cIEF = capillary isoelectric focusing 
GC = genome copy 
 
Fig. (4). Optimization of the different pH range ampholyte mixtures (pH 3-10 and pH 6-8) for high-resolution cIEF analysis of the 
AAV1, 8 and 9 serotypes. Traces: a) AAV1 with 1:1, b) AAV8 with 2:1 and 3) AAV9 with 2:1 mixture of wide and narrow range 
ampholytes. Peaks: 1-empty, 2,3-partially filled, 4-full capsids, 5-sample related impurity. All other conditions were the same as 
in Figure 1. (A higher resolution / colour version of this figure is available in the electronic copy of the article). 
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TEM = Transmission electron microscopy 
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